Part,  Chapter, Paragraph

 1   II,     5.  3.  9|     justification: third version. Ann Oncol 14(7):973-1005.~ ~
 2   II,     5.  3.  9|          end of the 20th century. Ann Oncol 14 (suppl 5):v128-v149.~ ~
 3   II,     5.  3.  9|      mortality in Europe in 2006. Ann Oncol 18(3):581-592.~ ~Gatta
 4   II,     5.  3.  9|        Wilking N (2007): Summary. Ann Onc 18 (Suppl 3): iii2–iii7.~ ~
 5   II,     5.  3.  9| EUROCARE-3 cancer registry areas. Ann Oncol 14:v28-v40.~ ~Micheli
 6   II,     5.  3.  9|           Results and commentary. Ann Oncol 14 (suppl 5):v61-v118.~ ~
 7   II,     5.  5.  3|      sclerosis registersEDMUS. Ann Neurol 36(suppl):S136–S139.~
 8   II,     5.  6.  6|     Rheumatic Disablement Survey. Ann Rheum Dis 52:6-13~Bergman
 9   II,     5.  6.  6|           Therapeutics (ESCISIT). Ann Rheum Dis 66(1):34-45~Cooper
10   II,     5.  6.  6|   osteoarthritis and, if so, why? Ann Rheum Dis 55:668-670~Frymoyer
11   II,     5.  6.  6|          the Patient Perspective. Ann Rheum Dis 64(10):1456-61~
12   II,     5.  6.  6|    factors affecting the outcome. Ann Chir Gynaecol 77:27-31~Kellgren
13   II,     5.  6.  6|         in Hip Replacement Rates. Ann Rheum Dis 62(3):222-6~National
14   II,     5.  6.  6| musculoskeletal diseases is high. Ann Rheum Dis. 62:644-650~Picavet
15   II,     5.  6.  6|   evidence for a secular decline. Ann Rheum Dis 52:254-257~Sprangers
16   II,     5.  6.  6|   relation to social deprivation. Ann Rheum Dis 57:649-655~Van
17   II,     5.  6.  6|          in 10 other populations. Ann Rheum Dis 48:271-280~van
18   II,     5.  6.  6|          in rheumatoid arthritis. Ann Intern Med 117:801-806~Woolf
19   II,     5.  6.  6|           joint decade 2000-2010. Ann Rheum Dis 59:81-82~Woolf
20   II,     5.  6.  6|         The role of rheumatology. Ann Rheum Dis. 66:281-282~Woolf
21   II,     5.  6.  6|         eight European countries. Ann Rheum Dis 63:342-347~Woolf
22   II,     5.  7.  7|      chronic renal insufficiency. Ann Intern Med 2004 Jul 20;141(
23   II,     5.  7.  7|        Renal Disease Study Group. Ann Intern Med 1999 Mar 16;130(
24   II,     5.  7.  7|         evidence from NHANES III. Ann Epidemiol 2007 Jan;17(1):
25   II,     5.  9.  7|        impact on quality of life. Ann Allergy Asthma Immunol.
26   II,     5.  9.  7|        with respiratory symptoms. Ann All Asthma Immunol 2005;
27   II,     5. 11.  7|      forgotten problem in Europe. Ann Oncol 2004;15(1):5-6.~ ~
28   II,     5. 12.  7|          cirrhosis, 1955 to 1990. Ann Epidemiol 4:480-486.~ ~La
29  III,    10.  2.  4|    Genetics, Biology and Disease. Ann Rev Gen Hum Genet, 1: 1-
30  III,    10.  5.  1|           Urban Park, Sweden. In: Ann. N.Y. Acad. Sci. 1023: 308-